Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hersch

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 22, 2002
Therapeutic effects of cystamine in a murine model of Huntington's diseaseAlpaslan Dedeoglu, James K Kubilus, Thomas M Jeitner, et al.
Nature Medicine|July 11, 2000
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington diseaseM Chen, V O Ona, M Li, et al.
Human Molecular Genetics|April 6, 2007
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease modelsGhazaleh Sadri-Vakili, Bérengère Bouzou, Caroline L Benn, et al.
The Journal of Biological Chemistry|April 2, 2011
Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble proteinJonathan H Fox, Teal Connor, Megan Stiles, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 23, 2007
Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 miceEdward C Stack, Alpaslan Dedeoglu, Karen M Smith, et al.
Human Molecular Genetics|October 24, 2002
HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosisRoshni R Singaraja, Shinji Hadano, Martina Metzler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 12, 2002
Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's diseaseCheryl L Wellington, Lisa M Ellerby, Claire-Anne Gutekunst, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 21, 2008
Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implicationsD Brocklebank, J Gayán, J M Andresen, et al.
Neuron|July 13, 1999
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegenerationJ G Hodgson, N Agopyan, C A Gutekunst, et al.
Neurology|January 26, 2006
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dGS M Hersch, S Gevorkian, K Marder, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 22, 2002
Therapeutic effects of cystamine in a murine model of Huntington's diseaseAlpaslan Dedeoglu, James K Kubilus, Thomas M Jeitner, et al.
Nature Medicine|July 11, 2000
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington diseaseM Chen, V O Ona, M Li, et al.
Human Molecular Genetics|April 6, 2007
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease modelsGhazaleh Sadri-Vakili, Bérengère Bouzou, Caroline L Benn, et al.
The Journal of Biological Chemistry|April 2, 2011
Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble proteinJonathan H Fox, Teal Connor, Megan Stiles, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 23, 2007
Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 miceEdward C Stack, Alpaslan Dedeoglu, Karen M Smith, et al.
Human Molecular Genetics|October 24, 2002
HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosisRoshni R Singaraja, Shinji Hadano, Martina Metzler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 12, 2002
Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's diseaseCheryl L Wellington, Lisa M Ellerby, Claire-Anne Gutekunst, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 21, 2008
Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implicationsD Brocklebank, J Gayán, J M Andresen, et al.
Neuron|July 13, 1999
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegenerationJ G Hodgson, N Agopyan, C A Gutekunst, et al.
Neurology|January 26, 2006
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dGS M Hersch, S Gevorkian, K Marder, et al.
Pageof 13